Related Experiment Video
Updated: Oct 8, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular risk assessment tools in Asia
Yuqing Zhang1, Huanhuan Miao1, Yook-Chin Chia2,3
1Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cardiovascular disease (CVD) risk assessment tools developed in Western countries need recalibration for Asian populations due to differing risk factors and CVD profiles. Developing new or adapting existing models with local data is crucial for accurate CVD risk prediction in Asia.
Area of Science:
- Public Health
- Epidemiology
- Cardiology
Background:
- Cardiovascular disease (CVD) poses a significant global health burden, particularly in Asia.
- Existing CVD risk assessment tools are predominantly Western-based.
- Asian populations exhibit distinct risk factor profiles and CVD patterns compared to Western populations.
Purpose of the Study:
- To highlight the limitations of Western CVD risk assessment tools in Asian populations.
- To emphasize the need for culturally specific or adapted risk models.
- To guide the development and application of appropriate CVD risk assessment strategies in Asia.
Main Methods:
- Review of existing literature on CVD risk assessment tools.
- Analysis of epidemiological data comparing Western and Asian populations.
- Discussion of the implications of differing risk factor prevalence and CVD profiles.
Main Results:
- Western CVD risk assessment tools show limitations when applied to Asian populations due to differences in hypertension, cholesterol levels, metabolic disorders, and stroke-to-coronary heart disease ratios.
- Existing Asian-specific models like China-PAR and JALS score are validated for national use.
- Many Asian regions currently utilize non-recalibrated established models.
Conclusions:
- Recalibration or development of new CVD risk assessment tools is essential for Asian populations.
- Hypertension requires greater emphasis in Asian CVD risk assessment due to higher stroke incidence.
- Adapting existing models with local epidemiological data is a viable alternative where resources are limited.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...